Home Health News Regeneron halts COVID-19 therapeutic trials on sick patients – One America News Network

Regeneron halts COVID-19 therapeutic trials on sick patients – One America News Network

1 min read
0
0
12

(Photo by David Ramos/Getty Images)

OAN Newsroom
UPDATED 3:50 PM PT – Friday, October 30, 2020

‘Regeneron’ has paused its trials on the sickest patients following safety concerns.

According to reports on Friday, the pharmaceutical company decided to stop giving its antibody-drug to coronavirus patients on ventilators or those receiving high amounts of oxygen.

However, the company has said it will continue the trial on patients with less severe bouts of the illness.

This comes as another pharmaceutical company, ‘Eli Lilly,’ ended trials on hospitalized patients on Monday after the drug was determined ineffective for severe cases of the coronavirus.

MORE NEWS: FBI Hiring Outside Contractor To Overhaul Use Of FISA Spying Tool

Let’s block ads! (Why?)


Source link

Load More Related Articles
Load More By admin
Load More In Health News

Leave a Reply

Your email address will not be published. Required fields are marked *

Check Also

Covid mutations do not appear to be helping the virus spread more rapidly, study says – CNBC

A man wearing a face mask waits for a train in the central train station during the COVID-…